Rising acquires three abbreviated new drug applications (ANDAs) from Nexus - MarketLine Financial Deals

Rising acquires three abbreviated new drug applications (ANDAs) from Nexus

Rising acquires three abbreviated new drug applications (ANDAs) from Nexus - MarketLine Financial Deals
Rising acquires three abbreviated new drug applications (ANDAs) from Nexus
Published Sep 15, 2015
2 pages — Published Sep 15, 2015
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Rising Pharmaceuticals, Inc. has acquired three abbreviated new drug applications (ANDAs) for the products Ciprofloxacin Ophthalmic Solution 3%, Levofloxacin Ophthalmic Solution 0.5%, and Diclofenac Sodium Ophthalmic Solution 0.1% from Nexus Pharmaceuticals, Inc.

  
Source:
Document ID
MA161261_151029
Country
Ticker
ACET=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Rising acquires three abbreviated new drug applications (ANDAs) from Nexus" Sep 15, 2015. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Rising-acquires-three-abbreviated-new-drug-applications-ANDAs-from-Nexus-2052-114792>
  
APA:
MarketLine Financial Deals. (2015). Rising acquires three abbreviated new drug applications (ANDAs) from Nexus Sep 15, 2015. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Rising-acquires-three-abbreviated-new-drug-applications-ANDAs-from-Nexus-2052-114792>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.